ANDA 76809, held by Ivax Sub Teva Pharms. Clozapine.
As of Nov 15, 2026, ANDA 76809 (Clozapine), held by Ivax Sub Teva Pharms, was first approved by FDA on Dec 16, 2005, with 30 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 16, 2005 | Original application | Approved |
| Jan 25, 2026 | Supplement 54Labeling · Standard review | Approved | None posted |
| Jan 25, 2026 | Supplement 52Labeling · Standard review | Approved | None posted |
| Jun 13, 2025 | Supplement 53REMS | Approved | None posted |
| Apr 5, 2024 | Supplement 51Labeling · Standard review | Approved | None posted |
| Apr 5, 2024 | Supplement 46Labeling · Standard review | Approved | None posted |
| Apr 5, 2024 | Supplement 42Labeling · Standard review | Approved | None posted |
| Nov 10, 2021 | Supplement 49REMS | Approved | None posted |
| Jul 29, 2021 | Supplement 47REMS | Approved | None posted |
| Feb 18, 2021 | Supplement 44REMS | Approved | None posted |
| Jan 16, 2019 | Supplement 38REMS | Approved | None posted |
| Apr 26, 2017 | Supplement 37Labeling · Standard review | Approved | None posted |
| Apr 26, 2017 | Supplement 36Labeling · Standard review | Approved | None posted |
| Apr 26, 2017 | Supplement 35Labeling · Standard review | Approved | None posted |
| Apr 26, 2017 | Supplement 32Labeling · Standard review | Approved | None posted |
| Apr 26, 2017 | Supplement 31Labeling · Standard review | Approved | None posted |
| Sep 15, 2015 | Supplement 30REMS | Approved | None posted |
| Sep 14, 2015 | Supplement 29Labeling · Standard review | Approved | None posted |
| Dec 8, 2014 | Supplement 28Labeling · Standard review | Approved | None posted |
| Dec 8, 2014 | Supplement 27Labeling · Standard review | Approved | None posted |
| Sep 26, 2014 | Supplement 7Labeling | Approved | None posted |
| Sep 26, 2014 | Supplement 4Labeling | Approved | None posted |
| Jul 31, 2013 | Supplement 26Labeling · Standard review | Approved | None posted |
| Dec 28, 2011 | Supplement 23Labeling | Approved | None posted |
| Jul 27, 2011 | Supplement 22Labeling | Approved | None posted |
| Apr 11, 2011 | Supplement 21Labeling | Approved | None posted |
| Oct 19, 2010 | Supplement 20Labeling | Approved | None posted |
| Apr 8, 2009 | Supplement 15Labeling | Approved | None posted |
| Sep 23, 2008 | Supplement 13Labeling | Approved | None posted |
| Aug 19, 2008 | Supplement 11Labeling | Approved | None posted |
| Apr 3, 2008 | Supplement 9Labeling | Approved | None posted |
| Dec 16, 2005 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters